Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.30 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25577606 | 0.95 | ALOX5 (0.39) | ALOX5GGPS1ALKPTGES2PRKDC | |
| SCHEMBL24839586 | 0.94 | ALOX5 (0.38) | ALOX5GGPS1ALKPTGES2PRKDC | |
| SCHEMBL24841224 | 0.94 | ALOX5 (0.39) | ALOX5GGPS1ALKPTGES2PRKDC | |
| SCHEMBL26015759 | 0.94 | ALOX5 (0.41) | ALOX5GGPS1ALKPTGES2PRKDC | |
| SCHEMBL24839563 | 0.94 | ALOX5 (0.39) | ALOX5GGPS1ALKPTGES2PRKDC | |
| SCHEMBL25577607 | 0.94 | ALOX5 (0.35) | ALOX5GGPS1ALKPRKDC | |
| SCHEMBL25578987 | 0.93 | ALOX5 (0.40) | ALOX5GGPS1PTGES2PRKDCPRMT5 | |
| SCHEMBL25577242 | 0.93 | ALOX5 (0.33) | ALOX5GGPS1ALK | |
| SCHEMBL24840384 | 0.93 | ALOX5 (0.40) | ALOX5GGPS1ALKPTGES2PRKDC | |
| SCHEMBL23375988 | 0.91 | ALOX5 (0.41) | ALOX5GGPS1ALKPTGES2PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| WO-2023273998-A1 | COMPOUND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE | 北京鼎材科技有限公司 | 2023-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | ESR1, L1CAM, ESR2 | ALOX5 1615/4885GGPS1 4169/4885ALK 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.